HIV Research & Clinical Practice, published by Taylor & Francis Ltd, is an essential open-access journal dedicated to advancing the knowledge and understanding of HIV-related research and clinical practices. With an ISSN of 2578-7489 and E-ISSN 2578-7470, this acclaimed journal is committed to disseminating cutting-edge studies and innovative treatment strategies within the infectious diseases and pharmacology fields, achieving a commendable Q2 ranking in both categories as of 2023. The journal's scope encompasses a broad range of topics from basic science to clinical application, providing a vital platform for researchers, clinicians, and students to exchange insights and foster collaboration. As an open-access publication since 2022, it ensures that high-quality research is accessible to a global audience, encouraging a greater understanding of HIV and its implications for public health. With its base in the United Kingdom and a convergence period from 2019 to 2024, HIV Research & Clinical Practice stands at the forefront of the fight against HIV/AIDS, making significant contributions to the clinical community and beyond.

AJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.

Surgery for Obesity and Related Diseases is an esteemed scholarly journal published by ELSEVIER SCIENCE INC, focusing on cutting-edge research and advancements in the field of obesity surgery. With an impressive impact factor and ranking in the 94th percentile among its peers in Medicine and Surgery, this journal maintains a prestigious position in the Q1 category of surgical studies. Since its inception in 2005, it has served as a vital platform for disseminating original research, clinical studies, and reviews that aim to improve patient outcomes and deepen our understanding of obesity-related diseases. The journal facilitates a wide array of access options, ensuring that professionals, researchers, and students across the globe can engage with current findings and best practices in surgical and medical treatment of obesity. As we look toward 2024 and beyond, Surgery for Obesity and Related Diseases remains committed to fostering innovation in surgical techniques and interdisciplinary approaches to solving one of the most pressing health challenges of our time.

Psychology & Health is a leading academic journal published by Taylor & Francis Ltd, dedicated to advancing the understanding of psychological influences on health and well-being. Since its inception in 1987, the journal has been pivotal in disseminating high-quality research, with a current ISSN of 0887-0446 and E-ISSN of 1476-8321. Recognized for its contributions to the field, it holds esteemed rankings, being classified in the Q2 quartile in Applied Psychology and Q1 quartile in Public Health (2023). With Scopus rankings placing it in the 87th percentile for Public Health and 80th in Applied Psychology, *Psychology & Health* provides researchers, professionals, and students with invaluable insights into the intersection of psychological research and health outcomes. The journal offers a rich platform for exploring contemporary issues and methodologies, encouraging submissions that advance the field and promote interdisciplinary dialogue. Although it is not an open-access journal, articles are available through institutional subscriptions, ensuring robust accessibility for the academic community.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.

AIDS REVIEWS, published by Permanyer Publishing, is a distinguished academic journal dedicated to providing comprehensive insights into the field of AIDS research. Since its inception in 2000, the journal has served as a vital platform for disseminating knowledge on various aspects of HIV/AIDS, including prevention, treatment advancements, and socio-medical implications. With a commendable Q3 ranking in both Infectious Diseases and Medicine (miscellaneous), as well as Pharmacology (medical) in 2023, the journal has made significant strides in the academic community, covering relevant topics and emerging trends up to 2024. Although not open access, AIDS REVIEWS continues to attract contributions from leading researchers and professionals, fostering a collaborative environment aimed at improving health outcomes related to AIDS. Located in Barcelona, Spain, this journal is an essential resource for anyone dedicated to advancing their understanding of this global health challenge.

AIDS, published by Lippincott Williams & Wilkins, stands as a premier journal within the fields of immunology and infectious diseases, reflecting a distinguished history since its inception in 1987 and offering insights that shape contemporary research and practice. With an impressive impact factor and categorized in the Q1 quartile across critical areas including Immunology, Infectious Diseases, and Immunology and Allergy, the journal showcases high-quality, peer-reviewed articles that consistently contribute to the advancement of knowledge and innovation in the fight against AIDS and related conditions. Researchers and professionals will find its content invaluable, as it brings forth groundbreaking studies, novel therapeutic approaches, and comprehensive reviews that inform both clinical practices and public health policies. Although not an open access journal, it remains a vital resource for those committed to addressing one of the most pressing global health challenges of our time.

INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, published by SAGE PUBLICATIONS LTD, is a premier scholarly journal that has been at the forefront of the fields of social psychiatry and mental health since its inception in 1955. With a bias towards empirical research and innovative methodologies, this journal aims to address critical issues at the convergence of social science and psychiatric practice, contributing significantly to the understanding of mental health from a societal perspective. Graded in the Q1 quartile for both Medicine (Miscellaneous) and Psychiatry and Mental Health, the journal ranks impressively at 28 out of 567 in its category, placing it in the top 5% of scholarly publications. Its rich content is vital for researchers, clinicians, and policymakers interested in the complexities of mental health behaviors and interventions. The journal is accessible in both print and online formats and continues to uphold its commitment to disseminating valuable and impactful research through to 2024 and beyond, ensuring it remains an essential resource in the academic community.